1. Home
  2. BAK vs PHAR Comparison

BAK vs PHAR Comparison

Compare BAK & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braskem SA ADR

BAK

Braskem SA ADR

HOLD

Current Price

$3.86

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.46

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAK
PHAR
Founded
1972
1988
Country
Brazil
Netherlands
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
BAK
PHAR
Price
$3.86
$16.46
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$4.40
$38.33
AVG Volume (30 Days)
2.4M
6.5K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.02
$10.04
Revenue Next Year
$7.04
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$8.60
52 Week High
$5.30
$21.34

Technical Indicators

Market Signals
Indicator
BAK
PHAR
Relative Strength Index (RSI) 53.77 46.37
Support Level $3.34 $15.96
Resistance Level $3.97 $17.28
Average True Range (ATR) 0.20 0.37
MACD 0.05 -0.11
Stochastic Oscillator 76.22 5.11

Price Performance

Historical Comparison
BAK
PHAR

About BAK Braskem SA ADR

Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: